Skip to main
  1. Stocks
  2. Stereotaxis Inc
  3. Forecast
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis is positioned for improving fundamentals because its core recurring revenue stream is already growing and early robotic catheter adoption is accelerating, with Q3 recurring revenue of $5.9M up 6% year over year and robotic catheter revenue up more than 400% from last year. The company also has clear system-side catalysts, as Q3 system sales of $3M rose 60% year over year on the first GenesisX and Synchrony revenue, while the large installed base and 100+ dedicated user accounts support a meaningful replacement cycle and broader commercialization. Although supply constraints at Osypka weighed on results and Q3 revenue of $8.9M fell short of the $9.6M estimate, management’s $24M convertible financing, $1.9M backlog, and plan for adjusted operating expenses of roughly $8M per quarter improve liquidity and support cash flow profitability by YE27.

Bears say

Stereotaxis is facing a fragile fundamental setup because it may not generate enough cash from operations and may need additional capital to sustain business activities, while hospital committees can delay or reject costly robotic system purchases. Revenue visibility has also weakened, as management cut 2026 expectations from above $40M to $35M after H1 revenue of $14M, signaling slower system sales despite a projected back-half mix of only $7M and $8M in recurring revenue. Execution risk remains elevated because innovation may lag the EP market, cybersecurity issues could hurt operations and reputation, and dependence on a concentrated shareholder base and key leader creates governance and retention risk.

Stereotaxis Inc (STXS) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction

Get the latest Stereotaxis Inc (STXS) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Stereotaxis Inc (STXS)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 3 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction

Get the latest Stereotaxis Inc (STXS) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Stereotaxis Inc (STXS)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover STXS stock data and trends